Post COVID-19 Pulmonary Fibrosis Management: A Systematic Review

Author:

Hamdi Yahya Al Turkey ,Aland S. Abdullah ,Harem K. Ahmed ,Bnar J. Hama Amin ,Yousif M. Mahmood ,Suhaib H. Kakamad ,Aso N. Qadir ,Hemin S. Mohammed ,Hemn H. Bayz ,Shevan M. Mustafa ,Sanaa O. Karim ,Hawbash M. Rahim ,Berun A. Abdalla ,Fahmi H. Kakamad

Abstract

Introduction Post-COVID-19 Pulmonary Fibrosis (PC-19-PF) is among the complications following COVID-19. It is the complication that is associated with the most amount of long-term impact on the respiratory system. Different physicians approach management in different ways; therefore, we conduct a study to neatly summarize all the different management and their possible outcomes. Methods The databases that were searched included CINAHL, PubMed/MEDLINE, Cochrane Library, Web of Science, and EMBASE to identify English language studies published up to October 5th, 2023. Results Initially, the systematic search conducted brought 150 papers. Out of the 150, 13 of them were included in this study. A total of 662 patients were included in the study, all with different managements for COVID-19-induced pulmonary fibrosis. The mean age was 61.8 years. Many comorbidities were observed in patients with COVID-19-induced pulmonary fibrosis. Different treatment regimens were picked based on the different conditions of the patients but as far as antifibrotics go, Pirfenidone and Nintedanib were the most commonly used ones. Conclusion Both antifibrotics and steroids seemed to yield justifiable outcomes when used separately as well as when used in combination.

Publisher

Barw Medical Journal

Reference43 articles.

1. Stuart A. Benign Tumors: Types, Causes, and Treatments [Internet]. WebMD. Available from: https://www.webmd.com/a-to-z-guides/benign-tumors-causestreatments#:~:text=Treatment%20of%20Benign%20Tumors

2. Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, et al. An overview of COVID-19. Journal of Zhejiang University. Science. B. 2020; 21(5):343. doi:10.1631/jzus.B2000083

3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020; 382(8):727-33. doi:10.1056/NEJMoa2001017

4. World Health Organization: WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Internet]. Who.int. World Health Organization: WHO

5. 2020. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3